¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"venous oxygen reserve"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • reserve starch grain
    ÀúÀå³ì¸»ÀÔÀÚ
  • reserve zone
    ¿¹ºñÃþ
  • systolic reserve
    ¼öÃà±â¿¹ºñ·Â
  • ventilation reserve
    ȯ±â¿¹ºñ·Â
  • azygos venous arch
    ȬÁ¤¸ÆÈ°
  • central venous catheter
    Áß½ÉÁ¤¸ÆÄ«Å×ÅÍ
  • central venous pressure
    Áß½ÉÁ¤¸Æ¾Ð
  • central venous pressure monitoring
    Áß½ÉÁ¤¸Æ¾Ð°¨½Ã
  • dural venous sinus
    °æÁú¸·Á¤¸Æ±¼, °æ¸·Á¤¸Æµ¿
  • jugular venous arch
    ¸ñÁ¤¸ÆÈ°, °æÁ¤¸Æ±Ã
  • jugular venous pressure
    ¸ñÁ¤¸Æ¾Ð, °æÁ¤¸Æ¾Ð
  • jugular venous pulse tracing
    ¸ñÁ¤¸Æ¸Æ¹ÚÃßÀû, °æÁ¤¸Æ¸Æ¹ÚÃßÀû
  • lateral venous lacuna
    °¡ÂÊÁ¤¸ÆÁÖ¸Ó´Ï
  • plantar venous network
    ¹ß¹Ù´ÚÁ¤¸Æ±×¹°, Á·ÀúÁ¤¸Æ¸Á
  • percutaneous venous catheter sampling
    ÇǺΰæÀ¯Á¤¸ÆÄ«Å×ÅÍÇ÷¾×äÃë(¹ý), °æÇÇÁ¤¸ÆÄ«Å×ÅÍÇ÷¾×äÃë(¹ý)
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • saturation dissolved oxygen
    Æ÷È­¿ëÇØ»ê¼Ò·®
  • oxygen requirement
    »ê¼Ò¿ä±¸·®
  • arterial oxygen saturation
    µ¿¸ÆÇ÷»ê¼ÒÆ÷È­µµ
  • oxygen saturation
    »ê¼ÒÆ÷È­µµ
  • arterial oxygen tension
    µ¿¸ÆÇ÷»ê¼ÒºÐ¾Ð
  • home oxygen therapy
    °¡Á¤»ê¼Ò¿ä¹ý
  • oxygen tension
    »ê¼ÒºÐ¾Ð, »ê¼ÒÀå·Â
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • reserve
    ¿¹ºñ·Â
  • reserve starch
    ÀúÀå³ì¸»
  • reserve substance
    ÀúÀå¹°Áú
  • reserve zone
    ¿¹ºñÃþ
  • systolic reserve
    ¼öÃà±â¿¹ºñ·Â
  • ventilation reserve
    ȯ±â¿¹ºñ·Â
  • azygous venous arch
    ȦÁ¤¸ÆÈ°
  • jugular venous arch
    ¸ñÁ¤¸ÆÈ°
  • venous admixture
    Á¤¸ÆÇ÷È¥ÇÕ
  • venous angle
    Á¤¸Æ°¢
  • venous blood
    Á¤¸ÆÇÇ
  • central venous pressure
    Áß½ÉÁ¤¸Æ¾Ð
  • central venous pressure monitoring
    Áß½ÉÁ¤¸Æ¾Ð°¨½Ã
  • venous capacitance
    Á¤¸Æ¿ë·®
  • venous capillary
    Á¤¸Æ¸ð¼¼Ç÷°ü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • anomalous pulmonary venous return
    ÆóÁ¤¸ÆÈ¯·ùÀÌ»ó.
  • anterior external vertebral venous plexus
    ¾Õ¹Ù±ùôÁÖÁ¤¸Æ¾ó±â
  • anterior internal vertebral venous plexus
    ¾Õ¼ÓôÁÖÁ¤¸Æ¾ó±â
  • areolar venous plexus
    Á¥²ÉÆÇÁ¤¸Æ¾ó±â
  • hepatic venous wedge pressure =wedged h.vein pressure
    Æó»ö°£Á¤¸Æ¾Ð( øÍßáÊÜð¡Øæäâ).
  • plantar venous arch
    ¹Ù´ÚÂÊÁ¤¸ÆÈ°
  • plantar venous network
    ¹ß¹Ù´ÚÁ¤¸Æ±×¹°
  • posterior external vetebral venous plexus
    µÚ¹Ù±ùôÁÖÁ¤¸Æ¾ó±â
  • posterior internal vertebral venous plexus
    µÚ¼ÓôÁÖÁ¤¸Æ¾ó±â
  • prostatic venous plexus
    Àü¸³»ùÁ¤¸Æ¾ó±â
  • pulmonary venous occlusion
    ÆóÁ¤¸ÆÆó¼â (¡­øÍáð).
  • pulmonary venous occlusion
    ÆóÁ¤¸ÆÆó¼â(øËð¡ØæøÍáð)
  • rectal venous plexus
    °ðâÀÚÁ¤¸Æ¾ó±â
  • renal venous collaterals
    ½ÅÃøºÎÁ¤¸Æ
  • renal venous pressure
    ½ÅÁ¤¸Æ¾Ð(¡­äâ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • expiratory reserve volume =ERV
    È£½Ä¼º ¿¹ºñ¿ëÀû(û¼ãÓàõçãÝáé»îÝ). ¸¶ Ãë È£±â¿¹ºñ·®, ¿¹ºñÈ£±â
  • expiratory reserve volume =ERV
    È£±â¿¹ºñ·®, ¿¹ºñÈ£±â·®, È£½Ä¼º ¿¹ºñ¿ëÀû
  • fusional reserve
    À¶ÇÕ¿©ºÐ
  • inspiratory reserve volume
    Èí½Ä(¼º)¿¹ºñ¿ëÀû(ýåãÓàõçãÝáé»îÝ), Èí±âÀܱⷮ( ¡­íÑѨåÖ).
  • pituitary reserve
    ³úÇϼöü¿¹ºñ·Â<--¿©·®(æ®Õá)
  • reserve air
    ¿¹ºñÈ£±â·®(çãÝáû¼Ñ¨åÖ), ¿¹ºñ ±â·®.
  • reserve blood
    ¿¹ºñÇ÷·®(çãÝáúìåÖ).
  • reserve cell
    ¿¹ºñ¼¼Æ÷(çãÝáá¬øà).
  • reserve force
    ¿¹ºñ·Â(çãÝáæ³).
  • reserve model
    ¿¹ºñ¸ðÇü(çãÝáÙ¼úþ).
  • reserve protein
    ÀúÀå´Ü¹éÁú.
  • reserve starch
    ÀúÀå³ì¸».
  • reserve starch grain
    ÀúÀå³ì¸»ÀÔÀÚ.
  • reserve substance
    ÀúÀå¹°Áú.
  • reserve zone
    ¿¹ºñÃþ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Dorsal venous network of foot
    ¹ßµîÁ¤¸Æ±×¹°
    [¿¾ ¿ë¾î] Á·¹èÁ¤¸Æ¸Á
  • Dorsal venous arch of foot
    ¹ßµîÁ¤¸ÆÈ°
    [¿¾ ¿ë¾î] Á·¹èÁ¤¸Æ±Ã
  • Plantar venous network
    ¹ß¹Ù´ÚÁ¤¸Æ±×¹°
    [¿¾ ¿ë¾î] Á·Ã´Á¤¸Æ¸Á
  • Vesical venous plexus
    ¹æ±¤Á¤¸Æ¾ó±â
    [¿¾ ¿ë¾î] ¹æ±¤Á¤¸ÆÃÑ
  • Internal carotid venous plexus
    ¼Ó¸ñÁ¤¸Æ¾ó±â
    [¿¾ ¿ë¾î] °æµ¿¸Æ°üÁ¤¸ÆÃÑ
  • Medullary venous plexus
    ¼ÓÁúÁ¤¸Æ¾ó±â
    [¿¾ ¿ë¾î] ¼öÁúÁ¤¸ÆÃÑ
  • Dorsal venous network of hand
    ¼ÕµîÁ¤¸Æ±×¹°
    [¿¾ ¿ë¾î] ¼ö¹èÁ¤¸Æ¸Á
  • Anterior external vertebral venous plexus
    ¾Õ¹Ù±ùôÁÖÁ¤¸Æ¾ó±â
    [¿¾ ¿ë¾î] Àü¿ÜÃß°ñÁ¤¸ÆÃÑ
  • Anterior internal vertebral venous plexus
    ¾Õ¼ÓôÁÖÁ¤¸Æ¾ó±â
    [¿¾ ¿ë¾î] Àü³»Ãß°ñÁ¤¸ÆÃÑ
  • Superficial palmar venous arch
    ¾èÀº¼Õ¹Ù´ÚÁ¤¸ÆÈ°
    [¿¾ ¿ë¾î] õÀåÁ¤¸Æ±Ã
  • Superficial subpapillary venous plexus
    ¾èÀºÀ¯µÎ¹ØÁ¤¸Æ¾ó±â
    [¿¾ ¿ë¾î] õÀ¯µÎÇÏÁ¤¸ÆÃÑ
  • Sacral venous plexus
    ¾ûÄ¡Á¤¸Æ¾ó±â
    [¿¾ ¿ë¾î] õ°ñÁ¤¸ÆÃÑ
  • Prostatic venous plexus
    Àü¸³»ùÁ¤¸Æ¾ó±â
    [¿¾ ¿ë¾î] Àü¸³¼±Á¤¸ÆÃÑ
  • Venous capillary
    Á¤¸Æ¸ð¼¼Ç÷°ü
    [¿¾ ¿ë¾î] Á¤¸Æ¼º¸ð¼¼Ç÷°ü
  • Venous part
    Á¤¸ÆºÎºÐ
    [¿¾ ¿ë¾î] Á¤¸ÆºÎ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • oxygen transport
    »ê¼Ò¿î¹Ý(ß«áÈê¡Úæ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
O2 both eyes; diatomic oxygen; molecular oxygen
PaO2 partial oxygen tension in arterial blood; partial pressure of oxygen in arterial blood
QO2 oxygen quotient; oxygen utilization
AJDO2 arteriojugular venous oxygen content difference
CjvO2 jugular venous oxygen content
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
RFR Renal functional reserve
WR Western Reserve
HRR heart rate reserve
AVP Ambulatory venous pressure
A-V Arterio-Venous
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • renal venous pressure
    ½Å Á¤¸Æ¾Ð
  • total anomalous pulmonary venous connection
    ÀüÆó Á¤¸Æ ¿¬°á ÀÌ»ó, ÃÑ Æó Á¤¸Æ ȯ·ù ÀÌ»ó, Æó Á¤¸Æ ¿¬°á ÀÌ»ó
    1. Á¿ìÀÇ ¸ðµç Æó Á¤¸ÆµéÀÌ Á½ɹæ°ú ¿¬°áµÇÁö ¾Ê°í ºñÁ¤»óÀûÀÎ °æ·Î¸¦ °ÅÃÄ Ã¼Á¤¸ÆÀ¸·Î ¿¬°áµÇ´Â °Í. ȯÀÚ°¡ »ýÁ¸Çϱâ À§Çؼ­´Â ¹Ýµå½Ã ½É¹æ Áß°Ý °á¼ÕÁõÀÌ ÀÖ¾î¾ß ÇÏ¸ç Æó Á¤¸ÆÀÌ ¿¬°áµÇ´Â ºÎÀ§¿¡ µû¶ó ½ÉÀå »óºÎÇü
  • vaginal venous plexus
    Áú Á¤¸Æ¾ó±â
  • veno-venous
    Á¤¸Æ°£ÀÇ
  • venous
    Á¤¸Æ¼ºÀÇ, Á¤¸ÆÀÇ
    Á¤¸Æ¿¡ ¼ÓÇÏ´Â.
  • venous angioma
    Á¤¸Æ¼º Ç÷°üÁ¾
  • venous hemorrhage
    Á¤¸Æ¼º ÃâÇ÷
  • venous hyperemia
    Á¤¸Æ¼º ÃæÇ÷
    µ¿ÀǾî=
  • venous injury
    Á¤¸Æ ¼Õ»ó
  • venous plasma blood glucose
    Á¤¸Æ Ç÷Àå Ç÷´çÄ¡, Á¤¸Æ Ç÷Àå Ç÷´ç
  • venous plexus
    Á¤¸ÆÃÑ
  • venous thrombosis
    Á¤¸Æ Ç÷ÀüÁõ
    Á¤¸Æ¿¡¼­ Ç÷·ùÀÇ Á¤Ã¼¿¡ ÀÇÇÑ ºñÁ¤»óÀû Ç÷Àü Çü¼º. ÇÏÁöÁ¤¸Æ¿¡ Àß »ý±â¸ç ÁÖ·Î Æó¼â¼ºÀÌ´Ù. Ç÷ÀüÀÇ ¼ººÐ¿¡ ¸Å¿ì ¸¹Àº ÀûÇ÷±¸°¡ ¼¯¿© ÀÖ¾î Àû»ö, ÀÀ·Î¼º, Á¤Ã¼¼º Ç÷ÀüÀ̶ó ºÎ¸£¸ç Àý´ÜÇØ º¸¸é ¾ûŲ ¼¶À¯¼Ò °¡´ÚÀ» º¼ ¼ö ÀÖ´Ù.
  • alveolar arterial oxygen gradient
    ÆóÆ÷µ¿¸Æ°£ »ê¼Ò ºÐ¾ÐÂ÷
  • alveolar-arterial oxygen difference
    ÆóÆ÷-µ¿¸Æ »ê¼Ò Â÷ÀÌ
  • biochemical oxygen demand
    »ý¹°È­ÇÐÀû »ê¼Ò ¿ä±¸, »ý¹°È­ÇÐÀû »ê¼Ò ¿ä±¸·®
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
carbon-oxygen lyases <enzyme> Enzymes that catalyze the cleavage of a carbon-oxygen bond by means other than hydrolysis or oxidation.
Registry number: EC 4.2
(12 Dec 1998)
reactive oxygen species Reactive intermediate oxygen species including both radicals and non-radicals. These substances are constantly formed in the human body and have been shown to kill bacteria and inactivate proteins, and have been implicated in a number of diseases. Scientific data exist that link the reactive oxygen species produced by inflammatory phagocytes to cancer development.
(12 Dec 1998)
chemical oxygen demand The amount of dissolved oxygen required to combine with chemicals in wastewater. A measure of the oxygen equivalent of that portion of organic matter that is susceptible to oxidation by a strong chemical oxidizing agent.
(05 Dec 1998)
rubredoxin-oxygen oxidoreductase <enzyme> Contains fad and a new type of haem; site of oxygen reduction to water by desulfovibrio gigas coupled with NADH oxidation
Registry number: EC 1.9.3.-
Synonym: rubredoxin oxidase
(26 Jun 1999)
phosphorus-oxygen lyases <enzyme> Enzymes that catalyze the cleavage of a phosphorus-oxygen bond by means other than hydrolysis or oxidation.
Registry number: EC 4.6
(12 Dec 1998)
critical dissolved oxygen concentration <biology> The minimum concentration of oxygen in the water needed for the growth of a culture which has been submerged, where oxygen is the limiting factor to the growth of the culture.
(09 Oct 1997)
heavy oxygen A stable oxygen isotope making up 0.20% of natural oxygen; used in mass spectrometry and in NMR studies of tissue.
Synonym: heavy oxygen.
(05 Mar 2000)
home oxygen therapy A form of oxygen that is typically delivered via nasal cannula. Commonly provided to those with severe heart or lung disease.
See: chronic obstructive pulmonary disease.
(27 Sep 1997)
hyperbaric oxygen High pressure oxygen, oxygen at a pressure greater than 1 atmosphere.
See: hyperbaric oxygenation.
Singlet oxygen, an excited or higher energy form of oxygen characterised by the spin of a pair of electrons in opposite directions, whereas electron spin is unidirectional in normal molecular oxygen Because of its great reactivity, singlet oxygen is a probable intermediate in most photo-oxidation reactions. Although it exists for no more than 0.1 sec, it may react with atmospheric pollutants to foster smog formation and may have harmful biological effects.
Triplet oxygen, the normal unexcited state of O2 in the atmosphere, in which the unpaired pair of electrons are so displaced that their magnetic fields are oriented in the same direction, resulting in paramagnetism; each of the heat-generated spectral lines of such oxygen can be split by a magnetic field into a triplet.
Compare: singlet oxygen.
(05 Mar 2000)
hyperbaric oxygen therapy <physiology> A pressurised chamber that allows for the delivery of oxygen in higher concentrations for therapeutic benefit.
Useful in the treatment of severe burns, peripheral vascular disease, carbon monoxide poisoning and decompression illness.
(04 Mar 1998)
singlet oxygen An energised but uncharged form of oxygen that is produced in the metabolic burst of leucocytes and that can be toxic to cells.
(18 Nov 1997)
dissolved oxygen <biochemistry> The concentration of oxygen dissolved in water, expressed in mg/l or as percent saturation, where saturation is the maximum amount of oxygen that can theoretically be dissolved in water at a given altitude and temperature.
(11 Jan 1998)
oxygen 1. <chemistry> A colourless, tasteless, odorless, gaseous element occurring in the free state in the atmosphere, of which it forms about 23 per cent by weight and about 21 per cent by volume, being slightly heavier than nitrogen. Symbol O. Atomic weight 15.96.
It occurs combined in immense quantities, forming eight ninths by weight of water, and probably one half by weight of the entire solid crust of the globe, being an ingredient of silica, the silicates, sulphates, carbonates, nitrates, etc.
Oxygen combines with all elements (except fluorine), forming oxides, bases, oxyacid anhydrides, etc, the process in general being called oxidation, of which combustion is only an intense modification.
at ordinary temperatures with most substances it is moderately active, but at higher temperatures it is one of the most violent and powerful chemical agents known. It is indispensable in respiration, and in general is the most universally active and efficient element.
It may be prepared in the pure state by heating potassium chlorate. This element (called dephlogisticated air by Priestley) was named oxygen by Lavoisier because he supposed it to be a constituent of all acids. This is not so in the case of a very few acids (as hydrochloric, hydrobromic, hydric sulphide, etc), but these do contain elements analogous to oxygen in property and action. Moreover, the fact that most elements approach the nearer to acid qualities in proportion as they are combined with more oxygen, shows the great accuracy and breadth of Lavoisier's conception of its nature.
Pharmacologic action: Increases the supply of oxygen to ischemic tissues. It is the most effective agent in emergency cardiac care.
Uses: Always administer oxygen during emergency cardiac care.
Dose: Nasal cannula with oxygen flow of 4 liters per minute provides FiO2 of about 30%. Nasal cannula with oxygen flow of 6-8 liters per minute provides FiO2 of 35-40%. Venturi mask can provide higher and more precise oxygen concentrations.
Potential complications: Ensure that oxygen is being delivered. Carefully check all connections. Oxygen toxicity develops only after several days of exposure to high FiO2. Increased FiO2 may cause hypoventilation in COPD patients dependent on hypoxic ventilatory drive. This is very rare and simply requires starting at lower FiO2, careful observation, and assisted ventilation if necessary.
Origin: F. Oxygene, from Gr. Sharp, acid + root of to be born. So called because originally supposed to be an essential part of every acid.
(17 Mar 2000)
oxygen-15 A cyclotron-produced, positron-emitting radioisotope of oxygen with a half-life of 122.2 seconds; used in studies of respiratory function and in positron emission tomography.
(05 Mar 2000)
oxygen-16 The common oxygen isotope, making up 99.76% of natural oxygen.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • depreciation reserve
    °¨°¡ »ó°¢ Áغñ±Ý
  • foreign currency reserve
    ¿ÜÈ­ º¸À¯(°í)
  • foreign reserve
    ¿ÜÈ­ º¸À¯(°í)
  • foreign reserve
    ¿ÜÈ­ Áغñ(±Ý)
  • game reserve
    =game preserve
  • gold reserve
    Á¤È­Áغñ
  • hidden reserve
    Àº´Ð Àû¸³±Ý
  • inner reserve
    (´ëÂ÷ ´ëÁ¶Ç¥¿¡ ½ÆÁö ¾ÊÀº)³»ºÎ À¯º¸±Ý;ºñ¹Ð Àû¸³±Ý
  • legal reserve
    ¹ýÁ¤Áغñ±Ý
  • naval reserve
    (±º)ÇØ±º¿¹ºñ¿ª
  • proportional reserve system
    (Á¤È­ Áغñ¿Í ÁöÆó ¹ßÇà°íÀÇ) ºñ·Ê ÁغñÁ¦
  • ready reserve
    ¿¹ºñ±º
  • reserve
    (Èʳ¯À» À§ÇÏ¿©)³²°Ü(¶¼¾î)µÎ´Ù;(Á¼®.¹æ µîÀ»)¿¹¾àÇØ µÎ´Ù;ÁöÁ¤ÇÏ´Ù;È®º¸ÇØ µÎ´Ù;´ÙÀ½À¸·Î ³Ñ±â´Ù;ÀÌ¿ù(¿¬±â)ÇÏ´Ù(postpond);»ï°¡´Ù;»ç¾çÇÏ´Ù;º¸À¯ÇÏ´Ù;º¸·ùÇÏ´Ù;(¾î¶² ±ÇÀÍ.Á¶¾àÀÇ Àû¿ë µîÀ»)À¯º¸ÇÏ´Ù;Á¦¿ÜÇÏ´Ù;(¼ºÃ¼.¼ºÂùÀÇ ÀϺθ¦)³²°ÜµÎ´Ù;¿î¸íÁþ´Ù;ÀúÃà;¿©Ãà;º¸Á¸¹°;¿¹
  • reserve bank
    ¿¬¹æ Áغñ ÀºÇà
  • reserve card
    µµ¼­ ´ëÃâ ÅëÁö¼­(Àü¿¡ ½ÅûÇÑ Ã¥ÀÌ ´ëÃâ °¡´ÉÇÔÀ» ¾Ë¸®´Â)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á